LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer-Reference-Cited by-同舟云学术

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Published:2016-02-19 Issue:11 Volume:7 Page:13047-13059
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lv Mingming¹,Xu Pengfei¹,Wu Ying¹,Huang Lei²,Li Wenqu²,Lv Shanshan¹,Wu Xiaowei³,Zeng Xin¹,Shen Rong¹,Jia Xuemei¹,Yin Yongmei²,Gu Yun⁴,Yuan Hongyan¹⁵,Xie Hui¹²,Fu Ziyi¹

Affiliation:

1. Nanjing Maternity and Child Health Medical Institute, Affiliated Nanjing Maternal and Child Health Hospital, Nanjing Medical University, Nanjing, China

2. First Affiliated Hospital, Nanjing Medical University, Nanjing, China

3. Department of Pharmacology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China

4. Department of Pathology, Affiliated Nanjing Maternal and Child Health Hospital, Nanjing Medical University, Nanjing, China

5. Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-mediated transfer of lncRNA RP3-340B19.3 promotes the progression of breast cancer by sponging miR-4510/MORC4 axis;Cancer Cell International;2024-09-10

2. Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses;RNA Biology;2024-06-04

3. Characterizing substructure via mixture modeling in large-scale genetic summary statistics;2024-01-31

4. MicroRNA Expression Profile in Early-Stage Breast Cancers;MicroRNA;2023-10-16

5. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis;Experimental Cell Research;2022-09